vTv Therapeutics Files Q1 2025 10-Q
Ticker: VTVT · Form: 10-Q · Filed: May 15, 2025 · CIK: 1641489
| Field | Detail |
|---|---|
| Company | Vtv Therapeutics Inc. (VTVT) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-filing, financials
TL;DR
vTv Therapeutics filed its Q1 2025 10-Q, check financials.
AI Summary
vTv Therapeutics Inc. filed a 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for vTv Therapeutics, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new information presented in the provided snippet.
Key Players & Entities
- vTv Therapeutics Inc. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250515 (date) — Filing Date
- DE (location) — State of Incorporation
- 1231 (date) — Fiscal Year End
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
In which state is vTv Therapeutics Inc. incorporated?
vTv Therapeutics Inc. is incorporated in Delaware (DE).
What is the fiscal year end for vTv Therapeutics Inc.?
The fiscal year end for vTv Therapeutics Inc. is December 31.
What is the SIC code for vTv Therapeutics Inc.?
The Standard Industrial Classification (SIC) code for vTv Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding vTv Therapeutics Inc. (VTVT).